Rayonier Advanced Materials (RYAM) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Mar, 2026Executive summary
Annual meeting scheduled for May 13, 2026, at the corporate headquarters in Jacksonville, FL.
Shareholders can vote online, by phone, email, or in person, with deadlines for voting set for May 10 and May 12, 2026, depending on shareholding method.
Voting matters and shareholder proposals
Election of three directors: Charles R. Eggert, David C. Mariano, and Scott M. Sutton, all recommended by the board.
Proposal to amend the Certificate of Incorporation to declassify the board of directors.
Proposal to eliminate supermajority voting provisions from the Certificate of Incorporation.
Advisory vote on executive compensation (say-on-pay) included.
Approval sought for a French Sub-Plan under the 2023 Incentive Stock Plan.
Board of directors and corporate governance
Board recommends all director nominees and supports declassification and removal of supermajority voting.
Latest events from Rayonier Advanced Materials
- Q2 2026 net sales and EBITDA rose, but asset impairments led to a $33M net loss.RYAM
Q2 2026 - Q1 2026 posted $319M sales, $81M net loss, $8M EBITDA, and positive free cash flow.RYAM
Q1 2026 - Director nominee resigned; votes for this nominee won't count, all other matters unchanged.RYAM
Proxy filing - Board refresh, executive pay alignment, and governance reforms headline this year's proxy.RYAM
Proxy filing - Board refresh, CEO change, and governance reforms highlight a focus on accountability and performance.RYAM
Proxy filing - 2026 targets positive cash flow, EBITDA growth, and new product launches amid disciplined execution.RYAM
Gabelli Funds Annual Specialty Chemicals Symposium - 2025 results showed lower revenue and EBITDA, with 2026 targeting free cash flow recovery.RYAM
Q4 2025 - Aiming to double EBITDA by 2027, leveraging price, cost, and biomaterials growth.RYAM
17th Annual Southwest IDEAS Conference - Q1 2025 net loss widened to $32M on lower sales and higher costs, but liquidity remains strong.RYAM
Q1 2025